NextCure, Inc. Email Format
Biotechnology ResearchMaryland, United States11-50 Employees
NextCure, Inc. is a clinical-stage biotechnology company based in Beltsville, Maryland. It aims to discover and develop innovative immunotherapies to treat cancer and other immune-related diseases by restoring normal immune function. Rather than focusing on a single immune cell type, the company analyzes biological pathways and cell interactions to understand how immune responses are regulated. Its discovery platform supports this approach by examining various immune cells to identify targets and understand how their components affect function. NextCure seeks therapies for patients who do not respond to current treatments or for cancer types not adequately addressed by existing options. In 2026, the company received FDA Fast Track designation for an anti-CDH6 antibody-drug conjugate targeting platinum-resistant ovarian cancer.